in Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida Glabrata Isolates

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01542-16
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Development of Echinocandin Resistance in Candida Krusei Isolates Following Exposure to Micafungin and Caspofungin in a BM Transplant Unit

Bone Marrow Transplantation
TransplantationHematology
2014English

FKS Mutations and Elevated Echinocandin MIC Values Among Candida Glabrata Isolates From U.S. Population-Based Surveillance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

In Vitro Interactions of Micafungin With Amphotericin B Against Clinical Isolates of Candida Spp.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Development of Echinocandin Resistance in Candida Tropicalis Following Short-Term Exposure to Caspofungin for Empiric Therapy

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

First Report on Echinocandin Resistant Polish Candida Isolates

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2019English

Mechanisms of Azole Resistance in Clinical Isolates of Candida Glabrata From Two Hospitals in China

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong in Vitro Activity Against Candida Glabrata and C. Krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Genetic Drivers of Multidrug Resistance in Candida Glabrata

Frontiers in Microbiology
Microbiology
2016English

De Novo Acquisition of Resistance to SCY-078 in Candida Glabrata Involves FKS Mutations That Both Overlap and Are Distinct From Those Conferring Echinocandin Resistance

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy